Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240–245 (2019).
Chen, L. et al. Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines. Sci. Transl. Med. 13, eabc2816 (2021).
Möller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in cancer. Nat. Rev. Cancer 20, 697–709 (2020).
Xu, R. et al. Extracellular vesicles in cancer-implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 15, 617–638 (2018).
Buzas, E. I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 23, 236–250 (2023).
Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).
Wang, S. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 13, eabb6981 (2021).
Xi, X. et al. Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination. Sci. Adv. 6, eaay7735 (2020).
Rao, L. et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat. Commun. 11, 4909 (2020).
Shimizu, A. et al. Exosomal CD47 plays an essential role in immune evasion in ovarian cancer. Mol. Cancer Res. 19, 1583–1595 (2021).
Sockolosky, J. T. et al. Durable antitumor responses to CD47 blockade require adaptive immune stimulation. Proc. Natl Acad. Sci. USA 113, E2646–E2654 (2016).
Vonderheide, R. H. CD47 blockade as another immune checkpoint therapy for cancer. Nat. Med. 21, 1122–1123 (2015).
Wilschut, J., Duezguenes, N. & Papahadjopoulos, D. Calcium/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. Biochemistry 20, 3126–3133 (1981).
Zhu, L. et al. In vitro selection of highly efficient G-quadruplex-based DNAzymes. Anal. Chem. 84, 8383–8390 (2012).
Kong, D. M., Xu, J. & Shen, H. X. Positive effects of ATP on G-Quadruplex-hemin DNAzyme-mediated reactions. Anal. Chem. 82, 6148–6153 (2010).
Bhuyan, S. K. et al. Directed evolution of a G-quadruplex peroxidase DNAzyme and application in proteomic DNAzyme-aptamer proximity labeling. J. Am. Chem. Soc. 145, 12726–12736 (2023).
Veglia, F. et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat. Commun. 8, 2122 (2017).
Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat. Rev. Cancer 21, 298–312 (2021).
Feng, M. et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat. Rev. Cancer 19, 568–586 (2019).
Chen, Y. C., Shi, W., Shi, J. J. & Lu, J. J. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective. J. Cancer Res. Clin. Oncol. 148, 1–14 (2022).
Lu, Y. et al. Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nat. Nanotech 17, 1332–1341 (2022).
Hauser, A. K. et al. Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials 105, 127–135 (2016).
Mulens-Arias, V., Rojas, J. M., Pérez-Yagüe, S., Morales, M. P. & Barber, D. F. Barber polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials 52, 494–506 (2015).
Batool, F. et al. Biologically synthesized iron nanoparticles (FeNPs) from Phoenix dactylifera have anti-bacterial activities. Sci. Rep. 11, 22132–22140 (2021).
Jiang, S. et al. Synergistic anticancer therapy by ovalbumin encapsulation‐enabled tandem reactive oxygen species generation. Angew. Chem. Int. Ed. Engl. 59, 20008–20016 (2020).
Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557–569 (2012).
Mantegazza, A. R. et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712–4722 (2008).
Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during cross presentation by dendritic cells. Cell 126, 205–218 (2006).
Kitai, Y. et al. DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J. Immunol. 198, 1649–1659 (2017).
Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling tumor cell-derived microparticles as vaccine. Cancer Immunol. Res. 3, 196–205 (2015).
Voets, E. et al. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint. J. Immunother. Cancer 7, 340–354 (2019).
Sikic, B. I. et al. First-in-human, first-in-class phase I trial of the anti-CD47 antibody hu5F9-G4 in patients with advanced cancers. J. Clin. Oncol. 37, 946–953 (2019).
DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369–382 (2019).
Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat. Med. 27, 212–224 (2021).
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism in the tumor microenvironment. Cell. Metab. 30, 36–50 (2019).
Gu, Z. et al. Mechanism of iron oxide-induced macrophage activation:tThe impact of composition and the underlying signaling pathway. J. Am. Chem. Soc. 141, 6122–6126 (2019).
Zhang, Y. et al. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 23, 898–914 (2013).
Gao, Y. et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma. Nat. Biomed. Eng. 4, 743–753 (2020).
Bangert, C. et al. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci. Immunol. 6, eabe2749 (2021).
Woller, N. et al. Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. J. Clin. Invest. 121, 2570–2582 (2011).
Liu, Y. et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat. Nanotechnol. 17, 206–216 (2022).
Bard, M. P. et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 31, 114–121 (2004).
Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382–386 (2018).
Xian, Y. et al. Controllable assembly of enzymes for multiplexed lab-on-a-Chip bioassays with a tunable detection range. Angew. Chem. Int. Ed. 130, 7625–7629 (2018).
Tian, F., Chao, L., Deng, J. & Sun, J. Microfluidic separation, detection, and engineering of extracellular vesicles for cancer diagnostics and drug delivery. Acc. Mater. Res. 3, 498–510 (2022).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41565-024-01783-2